A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma.
Shi X, Huang B, Zhu J, Yamaguchi T, Hu A, Tabuchi M, Watanabe D, Yoshikawa S, Mizushima S, Mizushima A, Xia S.
Shi X, et al. Among authors: mizushima a.
Medicine (Baltimore). 2023 May 19;102(20):e33521. doi: 10.1097/MD.0000000000033521.
Medicine (Baltimore). 2023.
PMID: 37335741
Free PMC article.